Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. 2003

Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
Department of Pathology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjyuku-ku, Tokyo 162-8640, Japan.

For the induction of mucosal immune responses by intranasal vaccination, cholera toxin B subunits (CTB) and Escherichia coli heat-labile toxin (LT) are often administered as mucosal adjuvants in order to enhance immune responses to mucosally co-administered bystander antigens. However, these toxin also are the causative agents of diarrhea. There is a demand for the establishment of an effective and safer adjuvant or vaccine that elicits mucosal immunity, but does not require the use of CTB or LT adjuvants. In order to induce protective mucosal immune responses in the nasal area against influenza virus infection, we have examined the recombinant protein composed of the complement component, C3d, which is fused to the secreted form of hemagglutinin (sHA-mC3d3) in the influenza-BALB/c mouse model. The fusion protein sHA-mC3d3, the secretory form of hemagglutinin, and the transmembrane form of HA (tmHA) from the influenza virus were intranasally administered to the mice with or without CTB containing a trace amount of holotoxin (CTB*) as an adjuvant. After intranasal administration of these proteins with CTB*, all mice produced nasal IgA and serum IgG antibodies (Abs) against the viral HA. In addition, viral infection was completely inhibited in these mice. In contrast, in the absence of the adjuvant, only sHA-mC3d3-induced locally secreted IgA and serum IgG Abs and provided complete protection against the influenza virus challenge. Thus, C3d fused to the influenza HA antigen is an effective and safe tool for mucosal vaccination.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females

Related Publications

Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
January 2005, Journal of medical virology,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
August 2000, Nature immunology,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
June 2000, Vaccine,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
October 2017, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
January 2012, Antiviral research,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
November 2010, Archives of virology,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
March 2011, PloS one,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
February 2013, Journal of microbiology (Seoul, Korea),
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
January 2015, Human vaccines & immunotherapeutics,
Izumi Watanabe, and Ted M Ross, and Shin-ichi Tamura, and Takeshi Ichinohe, and Satoshi Ito, and Hidehiro Takahashi, and Hirofumi Sawa, and Joe Chiba, and Takeshi Kurata, and Tetsutaro Sata, and Hideki Hasegawa
April 2010, Archives of virology,
Copied contents to your clipboard!